Crypto · IPO · Market Intelligence

Clear Signals for Market Momentum

Track IPOs, private companies, and crypto-related market movements in one modern intelligence platform.

Explore Data

sagi habasov

559 POSTS

Exclusive articles:

Mangal Electrical Industries Ltd. IPO: Key Details and Investor Insights

Introduction to Mangal Electrical IPO Mangal Electrical Industries Ltd., a well-established name in the power equipment manufacturing sector, is set to launch its Initial Public...

Legence Files for $100 Million IPO: A New Player in Systems and Services

The U.S. IPO pipeline continues to expand in 2025, with new filings across diverse industries adding momentum to a market that has been cautiously...

US IPO Market Update: Bullish Group and Miami International Close Out the Season

The U.S. IPO market continues to navigate a complex economic and financial landscape, with investors balancing optimism over renewed deal activity against uncertainty surrounding...

Carlsmed’s Nasdaq Debut: AI-Powered Spine Surgery Innovator Targets Market Leadership

Carlsmed Inc. (NASDAQ: CARL), a commercial-stage medical technology company specializing in AI-enabled personalized spine surgery, entered the public markets on July 22, 2025, marking...

Elite Express Holding Inc. Sets Course for Nasdaq Capital Market with Prudent IPO Strategy

Introduction Elite Express Holding Inc., operating in the logistics and transport sector in Vietnam, is charting a course toward public markets via a planned listing...

Breaking

SKN | Geothermal Developer Fervo Energy Files for Estimated $250 Million IPO

Fervo Energy, a next-generation geothermal energy developer, has filed...

SKN | Mobia Medical Files for $100M IPO as Neurostimulation Therapy Targets $30B Stroke Market

FDA-Approved Device Positions Company in High-Value Neurorehabilitation Segment Mobia Medical...

SKN | Amatuhi Holdings Raises IPO Range as Investor Demand Lifts Expected Proceeds by 60%

Revised Pricing Signals Stronger Market Interest Ahead of Nasdaq...

SKN | Alamar Biosciences Prices Upsized IPO at $17, the High End of the Range

Alamar Biosciences has priced its upsized initial public offering...
spot_imgspot_img